One-year observational study of vildagliptin with metformin to treat type 2 diabetes mellitus in real-life Russian clinical settings.

Trial Profile

One-year observational study of vildagliptin with metformin to treat type 2 diabetes mellitus in real-life Russian clinical settings.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Jun 2016

At a glance

  • Drugs Metformin (Primary) ; Vildagliptin (Primary) ; Vildagliptin/metformin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jul 2015 New trial record
    • 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
    • 09 Jun 2015 Primary endpoint has been met. (Number of patients achieving HbA1c of <7%)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top